TMCI
Treace Medical Concepts, Inc. Healthcare Medical Devices
8/12
Innovation Score
Patent Activity
3/3
50 patents found
OK_NORMALIZED
Cash Runway
2/3
38 months of cash remaining based on current burn rate.
Cash on hand: $45.6M
Cash on hand: $45.6M
Revenue Trajectory
0/3
Revenue: $205.3M
YoY Growth: -4.2%
YoY Growth: -4.2%
Management Quality
3/3
Insider ownership: 26.1%
SBC/Revenue: 21.9%
No reverse splits detected
SBC/Revenue: 21.9%
No reverse splits detected
Key Metrics
Market Cap
$308.8M
Revenue
$205.3M
Revenue Growth (YoY)
-4.2%
Cash on Hand
$45.6M
Cash Runway
38 months
Shares Outstanding
64.9M
Insider Ownership
26.1%
SBC / Revenue
21.9%
Sector / Industry
Healthcare / Medical Devices
Patents (50)
Match type: OK_NORMALIZED
- Cut guide with integrated joint realignment features
- Contoured bone plate with locking screw for bone compression, particularly across a tarsometatarsal joint
- Bone positioning and preparing guide systems and methods
- Compressor-distractor for angularly realigning bone portions
- Devices and techniques for treating lesser metatarsals of the foot
7-Step Risk Assessment
How TMCI maps to our micro cap methodology:
- Innovation Signal 50 patents identified. This suggests the company is investing in defensible IP.
- Cash Runway Check 38 months of runway. Comfortable buffer for execution.
- Revenue Trajectory -4.2% YoY growth on $205.3M revenue. Revenue declining — investigate whether this is temporary or structural.
- Management Alignment Insiders hold 26.1% of shares. SBC is 21.9% of revenue.
- Competitive Moat Review the company's 10-K for barriers to entry: patents, network effects, switching costs, regulatory approvals. This step requires manual research.
- Catalyst Identification Look for upcoming catalysts: FDA decisions, contract wins, product launches, partnerships. Check recent 8-K filings and earnings transcripts.
- Position Sizing Micro caps carry outsized risk. Consider position sizing relative to conviction level and portfolio concentration. This is a $308.8M company.
Financial Detail
Free Cash Flow
$1.4M
FCF Yield
0.5%
Return on Equity
-72.0%
Debt / Equity
102.1%
Gross Margin
79.5%
Profit Margin
-29.0%
Operating Margin
-33.0%
Price / Book
4.00
Current Ratio
2.90
Dividend Yield
None
Share Count Change (YoY)
N/A
Share Count Change (3yr)
N/A
Quality Flags
FCF Positive
Free Cash Flow Trend
Insufficient Data
Consecutive Years FCF Positive
0
Disclaimer: This is an automated screening tool, not investment advice. Micro cap stocks are inherently risky with low liquidity and high volatility. The innovation score is based on publicly available data and may not reflect the full picture. Steps 5-7 of the methodology require your own research. See our full disclaimer.
Last screened: 2026-08-08